HTG Molecular Diagnostics, Inc. (HTGMQ)
0.0001
0.00 (0.00%)
USD |
OTCM |
Dec 26, 15:28
Price Chart
Key Stats
| Price and Performance | |
|---|---|
| Market Cap | 0.0002M |
| 52 Week High (Daily) | Upgrade |
| 52 Week Low (Daily) | Upgrade |
| All-Time High (Daily) | Upgrade |
| Year to Date Total Returns (Daily) | Upgrade |
| 1 Month Total Returns (Daily) | Upgrade |
| 1 Year Total Returns (Daily) | -66.67% |
| Valuation | |
| PE Ratio | -- |
| PE Ratio (Forward) | Upgrade |
| PS Ratio | -- |
| Price to Book Value | -- |
| EV to EBITDA | Upgrade |
| Dividend | |
|---|---|
| Dividend | -- |
| Dividend Yield (Forward) | Upgrade |
| Financials | |
| Revenue (5 Year Growth) | Upgrade |
| Revenue (Quarterly YoY Growth) | Upgrade |
| EPS Diluted (5 Year Growth) | Upgrade |
| EPS Diluted (Quarterly YoY Growth) | Upgrade |
| Debt to Equity Ratio | -- |
| Return on Equity | Upgrade |
| Return on Assets | Upgrade |
| Risk | |
| Beta (5Y) | Upgrade |
| Max Drawdown (5Y) | 100.0% |
Profile
| HTG Molecular Diagnostics, Inc. engages in the provision of molecular technology solutions that facilitates molecular profiling. It serves the biopharmaceutical companies, academic research centres, and molecular testing laboratories. Its proprietary HTG EdgeSeq technology automates complex, highly multiplexed molecular profiling from solid and liquid samples, even when limited in amount. The company was founded by Bruce E. Seligmann in October 1997 and is headquartered in Tucson, AZ. |
| URL | http://www.htgmolecular.com |
| Investor Relations URL | http://investors.htgmolecular.com/phoenix.zhtml?c=253870&p=irol-irhome |
| HQ State/Province | Arizona |
| Sector | Health Care |
| Industry | Health Care Technology |
| Next Earnings Release | N/A |
| Last Earnings Release | Aug. 10, 2023 |
| Next Ex-Dividend Date | N/A |
| Last Ex-Dividend Date | N/A |
Ratings
Profile
| HTG Molecular Diagnostics, Inc. engages in the provision of molecular technology solutions that facilitates molecular profiling. It serves the biopharmaceutical companies, academic research centres, and molecular testing laboratories. Its proprietary HTG EdgeSeq technology automates complex, highly multiplexed molecular profiling from solid and liquid samples, even when limited in amount. The company was founded by Bruce E. Seligmann in October 1997 and is headquartered in Tucson, AZ. |
| URL | http://www.htgmolecular.com |
| Investor Relations URL | http://investors.htgmolecular.com/phoenix.zhtml?c=253870&p=irol-irhome |
| HQ State/Province | Arizona |
| Sector | Health Care |
| Industry | Health Care Technology |
| Next Earnings Release | N/A |
| Last Earnings Release | Aug. 10, 2023 |
| Next Ex-Dividend Date | N/A |
| Last Ex-Dividend Date | N/A |